« Back to Medicines list

Glutarol 10% w/v Cutaneous Solution

  • Name:

    Glutarol 10% w/v Cutaneous Solution

  • Company:
    info
  • Active Ingredients:

    Glutaraldehyde

  • Legal Category:

    Supply through pharmacy only

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 13/04/15

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 17/12/2020

Click on this link to Download PDF directly

Dermal Laboratories (Ireland) Ltd

129_1619620886

Address: Dermal Laboratories (Ireland) Ltd, 38 Main Street, Swords, Co Dublin, K67 E0A2, Ireland

Medical Information E-mail: info@dermal.ie

Company Products

Medicine NameActive Ingredients
Medicine Name Anhydrol Forte 20% w/v Cutaneous Solution Active Ingredients Aluminium Chloride Hexahydrate
Medicine Name Betacap Scalp Application 0.1% w/w Cutaneous Solution Active Ingredients Betamethasone Valerate
Medicine Name Capasal Therapeutic Shampoo Active Ingredients Coconut Oil, Distilled Coal Tar, Salicylic Acid
Medicine Name Emulsiderm Emollient Bath Additive/Cutaneous Emulsion Active Ingredients Benzalkonium Chloride, Isopropyl Myristate, Liquid Paraffin
Medicine Name Exterol 5% w/w Ear Drops, Solution Active Ingredients Urea Hydrogen Peroxide
Medicine Name Glutarol 10% w/v Cutaneous Solution Active Ingredients Glutaraldehyde
Medicine Name Ibugel 5% w/w Gel Active Ingredients Ibuprofen
Medicine Name Nicam 4% w/w Gel Active Ingredients Nicotinamide
Medicine Name Perinal Cutaneous Spray Active Ingredients Hydrocortisone
Medicine Name Psoriderm Cream Active Ingredients Distilled Coal Tar
Medicine Name Psoriderm Scalp Lotion Shampoo Active Ingredients Distilled Coal Tar
Medicine Name Salactol Collodion Active Ingredients Lactic Acid, Salicylic Acid
Medicine Name Salatac Gel Active Ingredients Lactic Acid, Salicylic Acid
1 - 0 of 13 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 17 December 2020 SPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Updated on 31 August 2018 SPC

Reasons for updating

  • File format updated to PDF

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

File format updated to PDF

Updated on 28 March 2017 SPC

Reasons for updating

  • New SPC for new product

Legal category: Supply through pharmacy only

Updated on 28 March 2017 SPC

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 6.3, the shelf-life has been changed from 36 months to 48 months.

In section 10 (Date of revision of the text), the date has been changed from April 2015 to March 2017. 

Updated on 13 April 2015 PIL

Reasons for updating

  • New PIL for new product

Updated on 13 April 2015 SPC

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text
  • Improved electronic presentation

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 4.8 Undesirable effects, the following text has been added:

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important.  It allows continued monitoring of the benefit/risk balance of the medicinal product.  Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517.  Website: www.hpra.ie; E-mail:medsafety@hpra.ie.



In section 10 Date of revision of the text, the date has changed to "April 2015"

Updated on 13 April 2015 PIL

Reasons for updating

  • Change to date of revision
  • Addition of information on reporting a side effect.

Updated on 24 July 2014 PIL

Reasons for updating

  • Removal/change of distributor
  • Change to date of revision

Updated on 4 December 2009 PIL

Reasons for updating

  • Change due to user-testing of patient information

Updated on 29 August 2007 PIL

Reasons for updating

  • Change to further information section

Updated on 11 September 2006 PIL

Reasons for updating

  • Change of active ingredient

Updated on 18 August 2006 SPC

Reasons for updating

  • Improved electronic presentation

Legal category: Supply through pharmacy only

Updated on 15 March 2006 SPC

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Updated on 22 February 2006 SPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Updated on 7 September 2004 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 12 June 2003 SPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Supply through pharmacy only